Organon & Co.

NYSE:OGN

Drug Manufacturers - General

Healthcare
$13.92 +0.04%

+$0.01 today

Market cap
$3.66B
Beta
1.54
P/E (TTM)
14.2
EPS (TTM)
$0.94
Dividend yield
0.60%
52W Low $5.69High $13.49

Volume 3.90M

Average 8.57M

OGN Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Organon & Co.NYSE: OGN

Weighted Avg Shares (Diluted) · Q3 FY2026 · quarter ended Sep 2026

Weighted avg shares (diluted) growth accelerates

Q3 FY2026 weighted avg shares (diluted) of 272.38M shares rose 4.5% year over year, ahead of the +2.3% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.7% from the prior quarter. Over 3 fiscal years it compounded at +0.7% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +4.5% holds above the trailing-twelve-month pace of +2.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
272.38M+0.7% QoQ
Last fiscal yearDec 2025
260.76M+0.6% YoY
LTMSep 2026
266.48M+2.3% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.5%——
1 year+0.6%——
3-year CAGR+0.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
260.76M USD
Year-over-year change
+0.6%
4-year CAGR
+0.7%

Weighted Avg Shares (Diluted) vs competitors

How OGN compares with its peers on the latest reported figures

  • OGN's LTM Sep 2026 weighted avg shares (diluted) of 266.48M shares is the 3rd highest of the 10 companies compared; the peer median is 106.71M shares.
  • Its year-over-year change of +2.3% is the 5th highest of 10, against a peer median of +0.7%.
  • Over three fiscal years its annual growth of +0.7% compares with a peer median of +0.5%.
OGN Competitors Peer median
Weighted Avg Shares (Diluted) for OGN and competitors
Company Period LTM YoY 3-year CAGR
NUVBNuvation Bio Inc.LTM Jun 2026353.26M +9.5%+16.4%
ALVOAlvotechLTM Mar 2026305.77M +6.0%+12.2%
OGNOrganon & Co.LTM Sep 2026266.48M +2.3%+0.7%
AUPHAurinia Pharmaceuticals Inc.LTM Jun 2026136.47M -5.1%-0.8%
SEMSelect Medical Holdings CorporationLTM Mar 2026123.47M -2.0%-0.3%
TLRYTilray Brands, Inc.LTM Feb 2026106.71M +24.0%+22.8%
MDPediatrix Medical Group, Inc.LTM Sep 202682.16M -4.5%+0.5%
GRDNGuardian Pharmacy Services, Inc.LTM Jun 202663.64M +2.5%+1.3%
HRMYHarmony Biosciences Holdings, Inc.LTM Jun 202658.74M +0.7%-1.4%
PAHCPhibro Animal Health CorporationLTM Mar 202640.89M +0.6%+0.2%
Peer median (excluding OGN) 106.71M+0.7%+0.5%

Competitors are the stored peer set for OGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue6.3B6.17B6.26B6.4B6.22B
Cost of Revenue2.38B2.29B2.52B2.69B2.85B
Gross Profit3.92B3.88B3.75B3.72B3.36B
Gross Margin62.2%62.8%59.8%58.0%54.1%
Research & Development443M471M528M469M366M
Selling, General & Admin1.67B1.7B1.89B1.76B1.71B
Operating Expenses2.01B2.18B2.42B2.23B2.09B
Depreciation & Amortization195M212M236M277M361M
EBITDA1.98B1.76B1.44B1.6B1.29B
EBITDA Margin31.4%28.4%22.9%25.1%20.8%
Operating Income1.92B1.71B1.33B1.49B1.29B
Operating Margin30.4%27.6%21.2%23.2%20.7%
Interest Income00000
Interest Expense258M422M527M520M504M
Other Income / Expenses(386M)(583M)(654M)(679M)(860M)
Income Before Tax1.53B1.12B673M807M425M
Pre-Tax Margin24.3%18.2%10.7%12.6%6.8%
Income Tax Expense178M205M(350M)(57M)238M
Net Income1.35B917M1.02B864M187M
Net Margin21.4%14.9%16.3%13.5%3.0%
EPS (Basic)5.333.614.013.360.72
EPS (Diluted)5.333.593.993.330.72
Weighted Avg Shares253.55M254.08M255.24M257.05M259.5M
Weighted Avg Shares (Diluted)253.55M255.17M256.27M259.15M260.76M

Organon & Co.

NYSE:OGN

Intrinsic Alpha fair value

Locked

Current Price

$13.92

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.